JEAN GENZALE: Open Payments
NPI 1972743243 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 17 payments from 14 companies in 2025. Trend: 2023 $149 · 2024 $380 · 2025 $1,194
Food & beverage: $1,194
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $460 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $178 |
| Abbott Laboratories | 2 | $146 |
| GENZYME CORPORATION | 1 | $120 |
| Neurelis, Inc. | 1 | $109 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| La Jolla Pharmaceutical Company | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
Products named: Rapiblyk, FREESTYLE LIBRE 3, FABRAZYME, VALTOCO, CAMZYOS, GIAPREZA, LEQVIO, Ambulatory Monitoring & Diagnostics Undivided.
Industry payments across LA — which companies pay providers there.
